Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Humacyte (HUMA) Return on Sales (2025)

Humacyte has reported Return on Sales over the past 1 years, most recently at 71.5% for Q4 2025.

  • Quarterly results put Return on Sales at 71.5% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 57.29% (changed N/A YoY), and the annual figure for FY2025 was 57.29%, changed.
  • Return on Sales for Q4 2025 was 71.5% at Humacyte, down from 35.08% in the prior quarter.
  • Over the last five years, Return on Sales for HUMA hit a ceiling of 35.08% in Q3 2025 and a floor of 104.45% in Q2 2025.